Journal for ImmunoTherapy of Cancer (Oct 2021)
Bispecific antibody targeting TROP2xCD3 suppresses tumor growth of triple negative breast cancer
- Huicheng Liu,
- Lili Bai,
- Liu Huang,
- Na Ning,
- Yijia Li,
- Xuejiao Dong,
- Qiuyang Du,
- Minghui Xia,
- Yufei Chen,
- Likun Zhao,
- Yanhu Li,
- Qingwu Meng,
- Yaqi Duan,
- Jie Ming,
- Andy Qingan Yuan,
- Xiang-Ping Yang
Affiliations
- Huicheng Liu
- Department of Immunology, School of Basic Medicine, Huazhong University of Science and Technology Tongji Medical College, Wuhan, Hubei, China
- Lili Bai
- Excyte Biopharma Ltd, Beijing, Haidian Dist, China
- Liu Huang
- Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology Tongji Medical College, Wuhan, Hubei, China
- Na Ning
- Department of Immunology, School of Basic Medicine, Huazhong University of Science and Technology Tongji Medical College, Wuhan, Hubei, China
- Yijia Li
- Excyte Biopharma Ltd, Beijing, Haidian Dist, China
- Xuejiao Dong
- Department of Immunology, School of Basic Medicine, Huazhong University of Science and Technology Tongji Medical College, Wuhan, Hubei, China
- Qiuyang Du
- Department of Immunology, School of Basic Medicine, Huazhong University of Science and Technology Tongji Medical College, Wuhan, Hubei, China
- Minghui Xia
- Department of Immunology, School of Basic Medicine, Huazhong University of Science and Technology Tongji Medical College, Wuhan, Hubei, China
- Yufei Chen
- Department of Immunology, School of Basic Medicine, Huazhong University of Science and Technology Tongji Medical College, Wuhan, Hubei, China
- Likun Zhao
- Excyte Biopharma Ltd, Beijing, Haidian Dist, China
- Yanhu Li
- Excyte Biopharma Ltd, Beijing, Haidian Dist, China
- Qingwu Meng
- Excyte Biopharma Ltd, Beijing, Haidian Dist, China
- Yaqi Duan
- Department of Pathology, School of Basic Medicine, Huazhong University of Science and Technology Tongji Medical College, Wuhan, Hubei, China
- Jie Ming
- Department of Breast and Thyroid Surgery, Wuhan Union Hospital, Huazhong University of Science and Technology Tongji Medical College, Wuhan, Hubei, China
- Andy Qingan Yuan
- Excyte Biopharma Ltd, Beijing, Haidian Dist, China
- Xiang-Ping Yang
- Department of Immunology, School of Basic Medicine, Huazhong University of Science and Technology Tongji Medical College, Wuhan, Hubei, China
- DOI
- https://doi.org/10.1136/jitc-2021-003468
- Journal volume & issue
-
Vol. 9,
no. 10
Abstract
No abstracts available.
